CY1106702T1 - Χρηση ενος συνδυασμου μιας πουρινης και ενος παραγοντα δοτη μονοξειδιου του αζωτου για την προληψη ή την αγωγη γενετησιων δυσλειτουργιων - Google Patents

Χρηση ενος συνδυασμου μιας πουρινης και ενος παραγοντα δοτη μονοξειδιου του αζωτου για την προληψη ή την αγωγη γενετησιων δυσλειτουργιων

Info

Publication number
CY1106702T1
CY1106702T1 CY20071100889T CY071100889T CY1106702T1 CY 1106702 T1 CY1106702 T1 CY 1106702T1 CY 20071100889 T CY20071100889 T CY 20071100889T CY 071100889 T CY071100889 T CY 071100889T CY 1106702 T1 CY1106702 T1 CY 1106702T1
Authority
CY
Cyprus
Prior art keywords
benefits
purine
prevention
treatment
combination
Prior art date
Application number
CY20071100889T
Other languages
English (en)
Inventor
Philippe Gorny
Original Assignee
Adenobio N. V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adenobio N. V. filed Critical Adenobio N. V.
Publication of CY1106702T1 publication Critical patent/CY1106702T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Inorganic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

Χρήση, σε συνδυασμό, μίας πουρίνης και ενός παράγοντα δότη μονοξειδίου του αζώτου, ως δραστικών συστατικών στην παρασκευή ενός φαρμάκου προοριζόμενου για την πρόληψη ή την αγωγή των διαταραχών της φυσιολογικής και/ή ανατομικής αποκρίσεως στη γενετήσια διέγερση στους ανθρώπους.
CY20071100889T 1998-12-02 2007-07-04 Χρηση ενος συνδυασμου μιας πουρινης και ενος παραγοντα δοτη μονοξειδιου του αζωτου για την προληψη ή την αγωγη γενετησιων δυσλειτουργιων CY1106702T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9815237A FR2786699B1 (fr) 1998-12-02 1998-12-02 Medicament destine notamment a prevenir ou traiter les dysfonctions sexuelles
PCT/FR1999/002993 WO2000032202A1 (fr) 1998-12-02 1999-12-02 Obtention et utilisation d'une combinaison d'une purine et d'un agent donneur de monoxyde d'azote pour prevenir ou traiter les dysfonctions sexuelles

Publications (1)

Publication Number Publication Date
CY1106702T1 true CY1106702T1 (el) 2012-05-23

Family

ID=9533506

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100889T CY1106702T1 (el) 1998-12-02 2007-07-04 Χρηση ενος συνδυασμου μιας πουρινης και ενος παραγοντα δοτη μονοξειδιου του αζωτου για την προληψη ή την αγωγη γενετησιων δυσλειτουργιων

Country Status (12)

Country Link
US (2) US6506736B1 (el)
EP (1) EP1137420B1 (el)
JP (1) JP2002531408A (el)
AT (1) ATE358490T1 (el)
AU (1) AU1564500A (el)
CY (1) CY1106702T1 (el)
DE (1) DE69935733T2 (el)
DK (1) DK1137420T3 (el)
ES (1) ES2285865T3 (el)
FR (1) FR2786699B1 (el)
PT (1) PT1137420E (el)
WO (1) WO2000032202A1 (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786699B1 (fr) * 1998-12-02 2002-10-04 Philippe Gorny Medicament destine notamment a prevenir ou traiter les dysfonctions sexuelles
WO2007075151A1 (en) * 2005-12-29 2007-07-05 Victor Pavlovich Kutnyak Composite vasodilator based on a no-group donator and a promoter
FR3005262A1 (fr) 2013-05-02 2014-11-07 Philippe Gorny Nouvelles compositions pharmaceutiques ou dietetiques permettant de masquer totalement l'amertume des sels d'arginine donnes a haute dose, sous forme liquide ou semi-liquide.
FR3012039A1 (fr) * 2013-10-22 2015-04-24 Philippe Olivier Gorny Medicament ou produit dietetique et son utilisation pour prevenir ou traiter les dysfonctionnements sexuels de l'homme et de la femme

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63179827A (ja) * 1987-01-20 1988-07-23 Fuso Yakuhin Kogyo Kk アデノシン三リン酸とマグネシウムイオンを含む安定な製剤
DE4117249C2 (de) * 1991-05-27 1998-05-14 Christian Dr Stief Linsidomin zur Behandlung erektiler Dysfunktionen
RU2064792C1 (ru) * 1992-03-02 1996-08-10 Свистов Александр Сергеевич Антиангинальное жидкое средство для трансдермального применения
GB2268871A (en) * 1992-07-04 1994-01-26 Bio Nutritional Health Service Composition for use as a food or food supplement
DK100392D0 (da) * 1992-08-10 1992-08-10 Gea Farmaceutisk Fabrik As 3- og 5-substituerede 1,2,3,4-oxatriazol-5-iminforbindelser og fremgangsmaade til fremstilling deraf, farmaceutisk praeparat indeholdende disse forbindelser samt forbindelsernes anvendelse til fremstilling af laegemidler
BR9203277A (pt) * 1992-08-21 1994-03-01 Cesar Roberto Dias Nahoum Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao
US5910316A (en) * 1992-08-24 1999-06-08 The United States Of America, As Represented By The Department Of Health And Human Services Use of nitric oxide-releasing agents to treat impotency
US5422343A (en) * 1992-12-21 1995-06-06 Otsuka Pharmaceutical Factory, Inc. Prophylactic and therapeutic composition for MRSA infection
US5594032A (en) * 1994-11-10 1997-01-14 Gonzalez-Cadavid; Nestor F. Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA
US5612060A (en) * 1995-05-25 1997-03-18 Alexander; J. Wesley Enhancement of transplant graft survival through nutritional immunomodulation and immunosuppressive therapy
JP4526047B2 (ja) * 1995-11-08 2010-08-18 雪印乳業株式会社 体力増強剤
US5824669A (en) * 1996-03-22 1998-10-20 Nitromed, Inc. Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
GB9608408D0 (en) * 1996-04-23 1996-06-26 Adams Michael A Treatment of erectile dysfunction
US6127363A (en) * 1997-10-28 2000-10-03 Vivus, Inc. Local administration of Type IV phosphodiesterase inhibitors for the treatment of erectile dysfunction
US5877216A (en) * 1997-10-28 1999-03-02 Vivus, Incorporated Treatment of female sexual dysfunction
US6124461A (en) * 1998-05-26 2000-09-26 Saint Louis University, Health Services Center, Research Administration Compounds, compositions, and methods for treating erectile dysfunction
AU4699299A (en) * 1998-06-26 2000-01-17 Nutracorp Scientific, Inc. Promoting nitric oxide and cyclic gmp activity
US6007824A (en) * 1998-07-09 1999-12-28 Duckett; Melvin J. Natural composition and method for the treatment of sexual dysfunction
FR2786699B1 (fr) * 1998-12-02 2002-10-04 Philippe Gorny Medicament destine notamment a prevenir ou traiter les dysfonctions sexuelles

Also Published As

Publication number Publication date
ES2285865T3 (es) 2007-11-16
FR2786699B1 (fr) 2002-10-04
EP1137420A1 (fr) 2001-10-04
ATE358490T1 (de) 2007-04-15
US20030195165A1 (en) 2003-10-16
AU1564500A (en) 2000-06-19
DE69935733D1 (de) 2007-05-16
FR2786699A1 (fr) 2000-06-09
WO2000032202A1 (fr) 2000-06-08
DE69935733T2 (de) 2007-12-27
DK1137420T3 (da) 2007-08-06
JP2002531408A (ja) 2002-09-24
US6506736B1 (en) 2003-01-14
PT1137420E (pt) 2007-07-04
EP1137420B1 (fr) 2007-04-04

Similar Documents

Publication Publication Date Title
MX9504415A (es) Eteres antivirales de isoesteres de sustrato de proteasa de aspartato.
CY1110721T1 (el) Χρηση glp-2 σε συνδυασμο με αλλο θεραπευτικο παραγοντα σε οστικες παθησεις
DE69332856D1 (de) Haarnadelförmiges ribozym
WO2005000161A3 (en) Methods and devices for occluding body lumens and/or for delivering therapeutic agents
TR200201067T2 (tr) Bir tramadol maddesi ve bir antikonvülsan ilaç içeren bileşimler
BR9715022A (pt) Método para tratar de doenças prostáticas usando formulações de vitamina d por liberação sistemática e/ou prolongada
HUP0002755A2 (hu) Eljárások szklerózis multiplexben szenvedő betegek kezelésére konszenzus interferonnal
ATE332136T1 (de) Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten
TR200103819T2 (tr) kanser tedavisinde ET743 terkipleri ve kullanımları
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
NZ516513A (en) Nitric oxide donors for inducing neurogenesis
CY1106702T1 (el) Χρηση ενος συνδυασμου μιας πουρινης και ενος παραγοντα δοτη μονοξειδιου του αζωτου για την προληψη ή την αγωγη γενετησιων δυσλειτουργιων
ID24184A (id) Obat untuk perawatan disfungsi ereksi
ES2178405T3 (es) Uso de selegilina o de desmetilselegilina para tratar heridas, quemaduras y lesiones cutaneas.
TR200102512T2 (tr) Tüm ruhsal bozukluklar, adaptasyon bozuklukları ve çeşitli kaygı-depresyon bozukluklarının tedavisinde ya da önlenmesinde yararlı tıbbi ürünlerin hazırlanması için saredutan ve onun farmasötik olarak kabul edilebilir tuzlarının kullanımı.
ATE275966T1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
NO970178L (no) Terpenoidderivater (sarcodictyiner) som er nyttige som antitumormidler
HUP0204208A2 (hu) Pruritus kezelésére szolgáló külsőleges gyógyszerkészítmény
GR3032224T3 (en) Therapeutic agent for threatened abortion.
DE69902879D1 (de) Pflanzliches antivirales mittel
HUP9901935A2 (hu) Gyógyszerek és terápiás szerek és más glikozaminoglikánok (GAG) dózisainak célbajuttatására alkalmas dóziskészlet
HUP0204180A2 (hu) Külsőleges készítmény és alkalmazása allergiás dermatitisz kezelésére
AR109456A2 (es) Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación
TR200100043T2 (tr) Ağrı tedavisinde ilaç hazırlanmasında tetra hidropiridin(veya 4-Hidroksipipeidin)-butilozollerin türevleri
NO960866D0 (no) Fremgangsmåte til behandling av leversykdom og lignende indikasjoner med vasodilaterende midler